Literature DB >> 9187412

Renal threshold for glucose in non-insulin-dependent diabetic patients.

B Ruhnau1, O K Faber, K Borch-Johnsen, B Thorsteinsson.   

Abstract

Measurement of glycosuria is still widely used for home monitoring of glycaemia control in non-insulin-dependent diabetes (NIDDM). This method has been criticized because the renal threshold for glucose (RTglu) varies between subjects. In order to evaluate the validity of RTglu by measuring corresponding measurements of blood and urine glucose in NIDDM patients, we studied the blood/urine glucose relationship in 24 NIDDM patients. RTglu estimated from 75 contemporary blood and urine glucose concentrations measured at home by each patient (h-RTglu) was compared with RTglu measured by a hyperglycaemic glucose clamp (c-RTglu). H-RTglu and c-RTglu, being 7.6 mmol/1 (range 5.5-12.4) and 10.3 mmol/1 (6.2-12.3) respectively (P < 0.005), were weakly correlated (R(S) = 0.35, P = 0.15). In conclusion, c-RTglu varies two-fold between NIDDM patients. RTglu detected by home monitored urine and blood glucose determinations underestimates the true RTglu, probably due to the splay phenomenon. However, the method for detection of RTglu used by us seems of clinical relevance, since it reflects the individual blood glucose level at which glucose is detectable in the urine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187412     DOI: 10.1016/s0168-8227(97)01389-2

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  13 in total

Review 1.  SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

Authors:  Ele Ferrannini; Anna Solini
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

2.  Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.

Authors:  Steven B Waters; Brian G Topp; Scott Q Siler; Charles M Alexander
Journal:  J Diabetes Sci Technol       Date:  2009-01

3.  Mathematical modeling of renal tubular glucose absorption after glucose load.

Authors:  Andrea De Gaetano; Simona Panunzi; Dimitris Eliopoulos; Thomas Hardy; Geltrude Mingrone
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

4.  Characteristics and Impact Factors of Renal Threshold for Glucose Excretion in Patients with Type 2 Diabetes Mellitus.

Authors:  Xiao Dan Yue; Jing Yu Wang; Xin Rong Zhang; Ju Hong Yang; Chun Yan Shan; Miao Yan Zheng; Hui Zhu Ren; Yi Zhang; Shao Hua Yang; Zhen Hong Guo; Bai Chang; Bao Cheng Chang
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

5.  Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels.

Authors:  Kunio Hieshima; Seigo Sugiyama; Akira Yoshida; Noboru Kurinami; Tomoko Suzuki; Hiroko Ijima; Fumio Miyamoto; Keizo Kajiwara; Katsunori Jinnouchi; Tomio Jinnouchi; Hideaki Jinnouchi
Journal:  J Diabetes Investig       Date:  2020-01-15       Impact factor: 4.232

6.  Renal glucose handling: impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes.

Authors:  Ele Ferrannini; Stephan A Veltkamp; Ronald A Smulders; Takeshi Kadokura
Journal:  Diabetes Care       Date:  2013-01-28       Impact factor: 19.112

7.  Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study.

Authors:  N Inagaki; K Kondo; T Yoshinari; N Maruyama; Y Susuta; H Kuki
Journal:  Diabetes Obes Metab       Date:  2013-07-14       Impact factor: 6.577

8.  Performance of Fasting Plasma Glucose and Postprandial Urine Glucose in Screening for Diabetes in Chinese High-risk Population.

Authors:  Bing-Quan Yang; Yang Lu; Jia-Jia He; Tong-Zhi Wu; Zuo-Ling Xie; Cheng-Hao Lei; Yi Zhou; Jing Han; Mei-Qi Bian; Hong You; De-Xian Mei; Zi-Lin Sun
Journal:  Chin Med J (Engl)       Date:  2015-12-20       Impact factor: 2.628

9.  Population Pharmacokinetics and Exposure-Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes.

Authors:  Kyle T Baron; Sreeraj Macha; Uli C Broedl; Valerie Nock; Silke Retlich; Matthew Riggs
Journal:  Diabetes Ther       Date:  2016-06-16       Impact factor: 2.945

10.  Identification of Newly Diagnosed Diabetes and Prediabetes Using Fasting Plasma Glucose and Urinary Glucose in a Chinese Population: A Multicenter Cross-Sectional Study.

Authors:  Juan Chen; Hai Jian Guo; Shan-Hu Qiu; Wei Li; Xiao-Hang Wang; Min Cai; Bei Wang; Xiao-Ning Li; Zi-Lin Sun
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.